State Court Activity
275+ pending in Cook County, IL; class action proceeding in D.P.R.; Pennsylvania class denied Jan. 2026; Georgia cases ongoing
Environmental · claims that ethylene oxide (EtO) emissions from commercial medical sterilizers and chemical plants caused cancer (leukemia, lymphoma, breast cancer) in nearby residents and workers
Defendant
Sterigenics U.S., LLC
MDL / Track
See litigation status
Judge
Plaintiffs
275 pending in Cook County against Steris Isomedix
Bellwether / Trial
Settlement Status
Track litigations for free. Save this matter, capture notes, and monitor live signals.
Case overview
Over 1,500 plaintiffs have filed state-court mass torts against commercial sterilizers including Sterigenics, B. Braun, and Steris, alleging cancers from chronic ethylene oxide (EtO) emissions. The litigation crested after a $363 million Cook County jury verdict in Kamuda v. Sterigenics (Sept. 19, 2022), followed by a $408 million Willowbrook settlement covering ~900 plaintiffs. New waves continue in Georgia (Smyrna, Covington), Pennsylvania (Allentown), Colorado (Lakewood), New Mexico (Santa Teresa), and California (Vernon/Maywood), with Steris now facing ~275 suits in Illinois state court over its former Waukegan Isomedix facility, per November 2024 SEC disclosures.
Causation Theory
EPA classified EtO as a known human carcinogen in 2016, with the agency's 2018 risk modeling showing cancer dangers 4.8 times above acceptable levels near the Willowbrook Sterigenics facility and risks of 500–1,000 excess cancers per million at peak exposure. OSHA's permissible exposure limit of 1 ppm (unchanged since 1984) is now 10 times higher than EPA's proposed 0.1 ppm workplace standard. Epidemiological meta-analyses of ~29,800 workers show suggestive dose-response relationships between cumulative EtO exposure and leukemia (p=0.05), with elevated standardized mortality ratios for stomach cancer (SMR 1.28, 95% CI 0.98–1.65).
Litigation status
EtO litigation remains active across multiple jurisdictions with no federal MDL consolidation. In Illinois, Cook County Circuit Court hosts nearly 275 pending cases against Steris Isomedix, with Knobbe v. Isomedix set for retrial after a January 2025 mistrial; Judge Frank Andreou presiding. In Puerto Rico, U.S. District Court for the District of Puerto Rico denied dismissal of negligence and nuisance claims in Jeanette Pérez-Maceira et al. v. Customed Inc. et al., No. 3:23-cv-01445 (D.P.R.), allowing discovery to proceed for a putative class. Pennsylvania state court rejected class certification for B. Braun Allentown facility residents in January 2026.
State Court Activity
275+ pending in Cook County, IL; class action proceeding in D.P.R.; Pennsylvania class denied Jan. 2026; Georgia cases ongoing
Geographic exposure
EPA identifies 23 of ~100 commercial sterilization/fumigation facilities nationwide emitting EtO at levels posing neighborhood cancer risk. Over 1,500 individual plaintiffs filed against sterilization providers through 2025. Active intake opportunities concentrated in California (Vernon/Maywood) and New Jersey (Franklin, Linden) where litigation nascent and SOL windows open; New Mexico state action remains pending.
Sterigenics facility — ~25 lawsuits filed Q2 2024, ongoing pending. Newly scrutinized site with active intake window.
Cosmed Group facility — first wave of plaintiffs filed 2023, facility sought bankruptcy protection. Active pending litigation.
ETO Sterilization-Plant #2 (2500 Brunswick Avenue) — EPA confirmed elevated lifetime cancer risk of 100-in-1 million or greater for surrounding community; maximum risk level 20-in-1 million in dark blue zone. Facility emits EtO for spice/nut sterilization since 1986. March 2024 NESHAP amendments apply.
Sterigenics U.S. facility — State AG Hector Balderas litigation filed Dec. 22, 2020, ongoing pending. State enforcement action for community exposure.
Sterigenics Cobb County facility — 79-plaintiff group settled $35 million (2023); property devaluation suits filed 2023 affecting 5,000+ homes per Cobb County Property Assessor. Mixed results: defense verdicts in Fornek v. Sterigenics, Glass v. B. Braun.
Medline/Steris facility — settled March 1, 2025. Mass tort resolution completed.
Sterigenics facility (now-closed) — nearly 900 lawsuits, $408 million settlement (2023); Kamuda v. Sterigenics $363 million verdict (Cook County). Litigation wave concluded; facility closure limits new claims.
B. Braun Medical facility — multiple PA residents litigation settled Feb. 18, 2025. Wave largely resolved.
Key defendants
Sterigenics U.S., LLC
Role: Sterilization Facility Operator
Core defendant in Willowbrook litigation. Paid $408M settlement (Jan. 2023) resolving 870+ claims following $363M Kamuda verdict. Facility shuttered 2019; consent decree allowed reopening under stricter controls but litigation exposure remains in other jurisdictions including New Mexico AG action.
Sotera Health Co.
Role: Parent Company
Sterigenics parent. Jointly liable in Willowbrook settlement. Denied facility posed safety risk while settling to avoid protracted litigation. Exposure extends to consolidated state court mass torts in Illinois and pending New Mexico AG action.
B. Braun Medical Inc.
Role: Medical Device Manufacturer
Allentown, Pennsylvania facility litigation. Mixed verdict posture: settled multiple PA resident claims (Feb. 2025) but secured defense verdict in Glass et al. (Dec. 2024). Continued exposure at operational sterilization sites.
Harcros Chemicals Inc.
Role: Chemical Manufacturer
Kansas City, Kansas facility operator. Facing active class action (Jeffries et al., D. Kan. Oct. 2025) alleging multi-decade emissions of EtO and other carcinogens. Successor liability theories target corporate predecessors including Elementis entities.
Medline Industries, Inc.
Role: Medical Supply Distributor
Lake County/Waukegan, Illinois facility co-defendant with Steris Isomedix. Settled resident claims (Mar. 2025). Previously survived 12(b)(6) challenge in Leslie v. Steris Isomedix (N.D. Ill.) but faced revived claims post-Berry.
Becton, Dickinson and Co.
Role: Medical Device Manufacturer
Covington, Georgia facility litigation. Settled resident claims (Oct. 2025). EPA identified BD Nebraska and Utah facilities as potential heightened cancer risk sites; litigation exposure expanding to additional geographic markets.
| Defendant | Role | Intelligence Note |
|---|---|---|
| Sterigenics U.S., LLC | Sterilization Facility Operator | Core defendant in Willowbrook litigation. Paid $408M settlement (Jan. 2023) resolving 870+ claims following $363M Kamuda verdict. Facility shuttered 2019; consent decree allowed reopening under stricter controls but litigation exposure remains in other jurisdictions including New Mexico AG action. |
| Sotera Health Co. | Parent Company | Sterigenics parent. Jointly liable in Willowbrook settlement. Denied facility posed safety risk while settling to avoid protracted litigation. Exposure extends to consolidated state court mass torts in Illinois and pending New Mexico AG action. |
| B. Braun Medical Inc. | Medical Device Manufacturer | Allentown, Pennsylvania facility litigation. Mixed verdict posture: settled multiple PA resident claims (Feb. 2025) but secured defense verdict in Glass et al. (Dec. 2024). Continued exposure at operational sterilization sites. |
| Harcros Chemicals Inc. | Chemical Manufacturer | Kansas City, Kansas facility operator. Facing active class action (Jeffries et al., D. Kan. Oct. 2025) alleging multi-decade emissions of EtO and other carcinogens. Successor liability theories target corporate predecessors including Elementis entities. |
| Medline Industries, Inc. | Medical Supply Distributor | Lake County/Waukegan, Illinois facility co-defendant with Steris Isomedix. Settled resident claims (Mar. 2025). Previously survived 12(b)(6) challenge in Leslie v. Steris Isomedix (N.D. Ill.) but faced revived claims post-Berry. |
| Becton, Dickinson and Co. | Medical Device Manufacturer | Covington, Georgia facility litigation. Settled resident claims (Oct. 2025). EPA identified BD Nebraska and Utah facilities as potential heightened cancer risk sites; litigation exposure expanding to additional geographic markets. |
Timeline
EPA Classifies EtO as Carcinogen
EPA publishes final evaluation of ethylene oxide to IRIS (Integrated Risk Information System), concluding EtO is carcinogenic and linked to unacceptably high cancer risk for chronic exposure.
Sterigenics Willowbrook Litigation Begins
Susan Kamuda v. Sterigenics U.S., LLC; Sotera Health filed, first major individual plaintiff case alleging EtO emissions from Willowbrook facility caused cancer. Case becomes bellwether for national litigation.
Illinois EPA Shuts Down Willowbrook Facility
Illinois Environmental Protection Agency issues seal order effectively closing Sterigenics Willowbrook facility. People v. Sterigenics U.S., LLC, No. 2018CH001329 (DuPage County, IL). Facility never reopens; Sterigenics announces permanent closure September 2019.
West Virginia Class Actions Filed
Letart v. Union Carbide Corp., Case No. 2:19-cv-00877 (S.D.W.Va.) and Sommerville v. Union Carbide Corp., Case No. 2:19-cv-00878 (S.D.W.Va.) filed, alleging decades of EtO emissions from Institute and South Charleston facilities. Marks expansion of litigation beyond sterilizers to chemical manufacturers.
$363M Verdict in Kamuda Trial
Cook County jury returns $363 million verdict for plaintiff Susan Kamuda against Sterigenics in first individual EtO trial. Verdict includes $325 million in punitive damages; sets benchmark for settlement negotiations nationwide.
$408M Willowbrook Settlement
Sterigenics and parent Sotera Health reach $408 million agreement to settle 800+ consolidated Willowbrook claims. Georgia plaintiffs separately settle 79 cases for $35 million.
EPA Finalizes 90% Emissions Reduction Rule
EPA announces final amendments to Clean Air Act NESHAP standards requiring 90% reduction in EtO emissions from commercial sterilization facilities. Compliance timelines range from two to three years based on facility usage levels; affects 88 facilities operated by approximately 50 companies.
Cosmed Bankruptcy; Steris Disclosures
Cosmed Group files for bankruptcy citing EtO litigation exposure. Steris discloses hundreds of pending EtO lawsuits. Defense verdicts begin emerging in 2024-2025 trials, shifting litigation dynamics as facility closures and settlements deplete plaintiff inventory at major sites.
Statute of limitations
No federal MDL established as of March 2026; cases proceed in state court mass torts. EPA interim registration review decision issued January 14, 2025 (90 FR 3208). April 5, 2024 NESHAP rule tightened emissions standards. Screen for last exposure date and diagnosis date to determine accrual. Federal preemption defenses raised but largely rejected in state court rulings to date.
Illinois
2 years from discovery of injury
Rule: 735 ILCS 5/13-202; discovery rule applies for latent disease claims per Kamuda v. Sterigenics U.S., LLC, Cook County Cir. Ct. (2022)
Discovery: Accrues when plaintiff knows or reasonably should know of injury and its causal connection to EtO exposure
Willowbrook/Sterigenics mass tort settled $408M June 2023; new filings focused on Medline (Waukegan) and other active facilities. No revival statute pending.
Georgia
2 years from injury discovery
Rule: O.C.G.A. § 9-3-33; discovery rule for toxic exposure claims per Smyrna/Covington Sterigenics litigation
Discovery: Accrues upon diagnosis or when causal link to EtO emissions reasonably discoverable
Smyrna facility closed; Covington (BD) remains operational. Defense verdicts in 2024-2025 noted in industry reporting; SOL still running for newly diagnosed.
Pennsylvania
2 years from discovery
Rule: 42 Pa.C.S.A. § 5524(2); discovery rule applies for occupational/environmental disease
Discovery: Accrues when plaintiff knows of injury and its cause
January 2026: Pa. state court declined class certification in EtO litigation per TruLaw update. Individual filings continue. Allentown area facilities active.
Colorado
2 years from discovery of injury
Rule: C.R.S. § 13-80-104(1)(a); discovery rule for toxic torts per Lakewood Sterigenics facility litigation
Discovery: Accrues upon reasonable discovery of injury and causal connection
December 2025: Colorado air regulators advancing April 2026 rulemaking for first state EtO emissions limits. Lakewood facility closed 2019; latency period supports ongoing filings.
California
2 years from discovery
Rule: Cal. Code Civ. Proc. § 335.1; discovery rule per Jolly v. Eli Lilly & Co., 751 P.2d 923 (1988)
Discovery: Accrues upon discovery of injury and its cause
Q2 2024: ~15 California residents filed v. Sterigenics U.S. per industry timeline. Facilities in Carson, Santa Teresa region. No revival window open.
⚠New Jersey
2 years from discovery
Rule: N.J.S.A. 2A:14-2; discovery rule for toxic torts per Lavelle v. Owens-Corning Fiberglas Corp., 824 A.2d 797 (2003)
Discovery: Accrues upon reasonable discovery of injury and its causal connection to EtO exposure
2024: Franklin facility became new litigation target with ~25 lawsuits filed. Emerging intake opportunity with recent diagnosis latency.
| State | SOL | Rule | Discovery Rule | Notes |
|---|---|---|---|---|
| Illinois | 2 years from discovery of injury | 735 ILCS 5/13-202; discovery rule applies for latent disease claims per Kamuda v. Sterigenics U.S., LLC, Cook County Cir. Ct. (2022) | Accrues when plaintiff knows or reasonably should know of injury and its causal connection to EtO exposure | Willowbrook/Sterigenics mass tort settled $408M June 2023; new filings focused on Medline (Waukegan) and other active facilities. No revival statute pending. |
| Georgia | 2 years from injury discovery | O.C.G.A. § 9-3-33; discovery rule for toxic exposure claims per Smyrna/Covington Sterigenics litigation | Accrues upon diagnosis or when causal link to EtO emissions reasonably discoverable | Smyrna facility closed; Covington (BD) remains operational. Defense verdicts in 2024-2025 noted in industry reporting; SOL still running for newly diagnosed. |
| Pennsylvania | 2 years from discovery | 42 Pa.C.S.A. § 5524(2); discovery rule applies for occupational/environmental disease | Accrues when plaintiff knows of injury and its cause | January 2026: Pa. state court declined class certification in EtO litigation per TruLaw update. Individual filings continue. Allentown area facilities active. |
| Colorado | 2 years from discovery of injury | C.R.S. § 13-80-104(1)(a); discovery rule for toxic torts per Lakewood Sterigenics facility litigation | Accrues upon reasonable discovery of injury and causal connection | December 2025: Colorado air regulators advancing April 2026 rulemaking for first state EtO emissions limits. Lakewood facility closed 2019; latency period supports ongoing filings. |
| California | 2 years from discovery | Cal. Code Civ. Proc. § 335.1; discovery rule per Jolly v. Eli Lilly & Co., 751 P.2d 923 (1988) | Accrues upon discovery of injury and its cause | Q2 2024: ~15 California residents filed v. Sterigenics U.S. per industry timeline. Facilities in Carson, Santa Teresa region. No revival window open. |
| ⚠New Jersey | 2 years from discovery | N.J.S.A. 2A:14-2; discovery rule for toxic torts per Lavelle v. Owens-Corning Fiberglas Corp., 824 A.2d 797 (2003) | Accrues upon reasonable discovery of injury and its causal connection to EtO exposure | 2024: Franklin facility became new litigation target with ~25 lawsuits filed. Emerging intake opportunity with recent diagnosis latency. |
Live intelligence
AI litigation brief
EtO Sterilization remains active litigation category with 101 current signals in the accepted feed.
Overview
EtO litigation remains active across multiple jurisdictions with no federal MDL consolidation. In Illinois, Cook County Circuit Court hosts nearly 275 pending cases against Steris Isomedix, with Knobbe v. Isomedix set for retrial after a January 2025 mistrial; Judge Frank Andreou presiding. In Puerto Rico, U.S. District Court for the District of Puerto Rico denied dismissal of negligence and nuisance claims in Jeanette Pérez-Maceira et al. v. Customed Inc. et al., No. 3:23-cv-01445 (D.P.R.), allowing discovery to proceed for a putative class. Pennsylvania state court rejected class certification for B. Braun Allentown facility residents in January 2026.
Key developments
Trajectory
Court filings and press coverage are both active, pointing to sustained litigation pressure rather than a one-off headline cycle. 5 live sources are contributing current context.
Editorial intelligence
Editorial coverage should stay tied to source-backed developments and avoid placeholder status copy for EtO Sterilization.
Generated Jun 13, 2026, 9:00 AM UTC
101 events detected
Google News (60)
EPA Moves To Weaken Air Pollution Limits For Chemical Linked To Cancer El Clasico (7fIOOVcDvK) - Mshale
Henrico facility fined for emitting cancer-causing gas - WWBT
Henrico sterilization facility facing $53K fine after 600-pound toxic gas release - WTVR.com
Monitor Ultra-Low Ethylene Oxide Emissions in Sterilization Facilities - AZoCleantech
Judge denies company’s attempt to keep cancer patients’ cases from going to trial - LAist
Tens of thousands may be at risk as EPA looks to repeal rule limiting cancer-causing gas - KOMO
Cancer-causing chemicals - LAist
Virginia joins lawsuit to block EPA rollback of emission standards - Virginia Mercury
EPA ETO Sterilization Standards - AdvaMed® - Advanced Medical Technology Association®
AdvaMed’s Comments on EPA Sterilization Emissions Standards - AdvaMed® - Advanced Medical Technology Association®
EPA proposes changes to ethylene oxide pollution limits for medical sterilization - MSN
Democrat-Led States Ask EPA to Keep Biden’s Ethylene Oxide Rule - Bloomberg Law News
ACC Statement on EPA’s Proposals to Address Ethylene Oxide in Sterilization and Pesticide Uses - American Chemistry Council
Attorney General Raoul Leads Coalition Against EPA’s Proposal To Gut National Limits On Toxic Ethylene Oxide Pollution - RiverBender.com
POISONED USA: Medical Sterilizer Exposed Thousands to Cancer-Causing Chemical - Hunterbrook
SCV News | Environmental Health Releases Cancer Risk Values for Acrolein, Ethylene Oxide - SCVNews.com
SCV News | OEHHA Releases Draft Cancer Risk Values for Acrolein, Ethylene Oxide - SCVNews.com
California begins review of two carcinogens, points to new data about cancer risk - Courthouse News
Ten times worse than benzene — California updates its science on two chemicals in everyday air - Los Angeles Times
Resident files class action lawsuit against B. Braun over cancer-causing chemical emissions - WFMZ.com
Two chemicals in everyday California air may pose ‘unacceptable' cancer risk, findings suggest - Los Angeles Times
Low-Income US Neighbourhoods At Risk As Trump Rollback Allows Release Of Eight Tons Of Cancer-Causing Ethylene Oxide - International Business Times
EPA Emissions Standards Proposal Would Reduce Regulatory Burdens - Bloomberg Law News
EPA raises concerns about ethylene oxide emissions from B. Braun plant near Allentown - WFMZ.com
State, feds investigating leak of cancer-causing chemical at Croda plant - The News Journal
Toxic gas emissions from Florida plant spark health lawsuits - MSN
EPA Extends Comment Period on Proposed Revisions to Ethylene Oxide Standards - Office of Advocacy (.gov)
What to know about toxic ethylene oxide in Tampa Bay - Tampa Bay Times
A company released toxic gas in Tampa Bay for years. No one stopped it - Tampa Bay Times
Trump’s EPA moves toward deregulating a cancer-causing gas - prismreports.org
Trump’s EPA moves toward deregulating ethylene oxide - prismreports.org
Health concerns grow over cancer-causing gas as EPA reconsiders emission standards - WWBT
The Poison Next Door: Measuring Risk in Cancer Alley - Hopkins Bloomberg Public Health Magazine
What Is Ethylene Oxide? The Cancer Risk in Texas, and the Ongoing Fight for Clean Air - Sierra Club
EPA’s Proposal to Rescind Ethylene Oxide Emissions Standards for Commercial Sterilizers - Harvard University
Protect communities from this toxic air pollutant - Earthjustice
EPA’s Proposed Reconsideration of Ethylene Oxide Emissions Standards for Sterilization Facilities – April 16, 2026 - Office of Advocacy (.gov)
Scientists urge EPA not to weaken ethylene oxide emissions standards - MedTech Dive
Erie sterilization facility has new owner and lower EtO emissions - goerie.com
Erie sterilization facility has new owner and lower EtO emissions - Erie Times-News
Henrico residents raise awareness of toxic chemical used in two local plants - VPM
B. Braun resolves majority of lawsuits alleging that cancer-causing emissions were released from Hanover Twp. facility - WFMZ.com
EPA proposes amendments to weaken emission limits on ethylene oxide - The Cancer Letter
EPA seeks weaker ethylene oxide emission standards - Chemical & Engineering News
Pollution Exclusion/Permitted Emissions: Federal Appellate Court Addresses Coverage Question Related to Ethylene Oxide - JD Supra
EPA seeks weaker ethylene oxide emission standards - C&EN
EPA Proposes Revisions to EtO Standards for Commercial Sterilization Facilities - Office of Advocacy (.gov)
EPA May Ease Restrictions on a Cancer-Causing Gas Used to Clean Medical Equipment - Cancer Health
The Ethylene Oxide Dilemma: Cancer Risk, Legal Battles, and America’s Medical Supply - American Council on Science and Health
Facing multiple lawsuits, Georgia medical sterilization facility to shutter - AJC.com
Ethylene Oxide (EtO) Emissions Standards for Commercial Sterilizers - Harvard University
Facing multiple lawsuits, Georgia medical sterilization facility to shutter - Atlanta Journal-Constitution
Facing multiple lawsuits, Georgia medical sterilization facility to shutter - AJC.com
EPA Seeking to Curb Restrictions on Cancer-Linked Ethylene Oxide - The Well News
EPA Seeking to Curb Restrictions on Cancer-Linked Ethylene Oxide - The Well News
EPA proposes weakening ethylene oxide emission regulations - MedTech Dive
DURBIN, DUCKWORTH, SCHNEIDER SLAM TRUMP EPA PROPOSED WEAKENING OF EtO PROTECTIONS - Congressman Brad Schneider (.gov)
E.P.A. Moves to Weaken Limits on a Cancer-Causing Gas - The New York Times
EPA proposes weakening ethylene oxide emission regulations - MedTech Dive
E.P.A. Moves to Weaken Limits on a Cancer-Causing Gas - The New York Times
Future science OA • Ye J • PMID 42257425 • Journal Article.
The Journal of bone and joint surgery. American volume • Farid YR • PMID 42228767 • Journal Article.
Environmental science & technology • Ge X • PMID 42222938 • Journal Article.
Chemical research in toxicology • Lu K • PMID 42175963 • Journal Article.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology • Etemadi A • PMID 42149091 • Journal Article.
IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT ARC Specialty Products, Balchem Corporation (d/b/a/ ARC Specialty Products) Petitioner, v. UNITED STATES ENVIRONMENTAL PROTECTION AGENCY, Respondent. Case No. __________________ PETITION FOR REVIEW Pursuant to Rule 15 of the Federal Rules of Appellate Procedure and 7 U.S.C. § 136n, ARC Specialty Products, Balchem Corporation (d/b/a/ ARC S
EPA regulatory on Mar 25 for EtO Sterilization. Regulatory developments can change intake posture and motion practice quickly.
EPA FOIA Log Received between 01/01/2025 and 03/31/2025 Request ID Requester Name Organization Request Description Received Date 2025-EPA-02431 Huhmann, Penelope Dominion Due Diligence I am working on a Phase I Environmental Site Assessment of the Proposed Futurity Tower located in Billings, MT and have identified the following state-regulated facilities as a potential Recognized Environmental Con
EPA regulatory on Mar 25 for EtO Sterilization. Regulatory developments can change intake posture and motion practice quickly.
Ethylene Oxide (EtO) | US EPA # Ethylene Oxide (EtO) ## EPA Releases Proposal for Commercial Sterilizers to Safeguard the Supply of Life-Saving Medical Tools EPA has proposed amendments to the Biden-era 2024 National Emissions Standards for Hazardous Air Pollutants (NESHAP) for Ethylene Oxide (EtO) Commercial Sterilization Facilities to ensure consistency with the law and gold standard science. Le
EPA regulatory on Mar 18 for EtO Sterilization. Regulatory developments can change intake posture and motion practice quickly.
This article covers the EPA's historical regulatory actions on ethylene oxide emissions from chemical manufacturing and sterilization facilities, directly related to the environmental and health claims in EtO litigation.
EPA regulatory on Mar 13 for EtO Sterilization. Regulatory developments can change intake posture and motion practice quickly.
EPA Releases Proposal for Commercial Sterilizers to Safeguard the Supply of Life-Saving Medical Tools | US EPA # EPA Releases Proposal for Commercial Sterilizers to Safeguard the Supply of Life-Saving Medical Tools March 13, 2026 Contact Information EPA Press Office (press@epa.gov) WASHINGTON — U.S. Environmental Protection Agency (EPA) proposed amendments to the Biden-era 2024 National Emissions
EPA News Release regulatory on Mar 13 for EtO Sterilization. Regulatory developments can change intake posture and motion practice quickly.
FRANCO v. B. BRAUN MEDICAL, INC.
Eastern District of Pennsylvania
Federal court result for EtO Sterilization: NOTICE OF REMOVAL by UNITED STATES OF AMERICA from CCP, case number 230702787., filed by UNITED STATES OF AMERICA. (Attachments: # 1 Civil Coversheet, # 2 Civil Coverhsheet, # 3 Designation, # 4 Exhibit A Oct 22 2025 Ltr and Subpoena, # 5 Exhibit B 2026.04.24 Ltr. from EPA to T.Bosworth, # 6 Exhibit C Pltff 5-3-26 MTC Compliance with Subpoena to EPA, # 7 Exhibit D Praecipe to Substitute Order)(SCOTT, JOHN) (Entered: 05/18/2026) • Exhibit A Oct 22 2025 Ltr and Subpoena • District Court, E.D. Pennsylvania • 2:26-cv-03408 • Wendy Beetlestone
No recent legislative signals. Monitoring is active — this section updates automatically.
Workbench
Sign in to save litigations, capture notes, and monitor live signals. Sign in for unlimited.
LexGenius Ranking
48Score
Fresh items are present but not yet surging
Monitoring
Live
monitoring
Last: Jun 13, 2026, 9:00 AM UTC
Next: 16:20
Source Monitoring
PACER
PACER
Google News
PubMed
EPA
Event feed
101
events detected
AI Brief
EtO Sterilization remains active litigation category with 101 current signals in the accepted feed.
Overview
EtO litigation remains active across multiple jurisdictions with no federal MDL consolidation. In Illinois, Cook County Circuit Court hosts nearly 275 pending cases against Steris Isomedix, with Knobbe v. Isomedix set for retrial after a January 2025 mistrial; Judge Frank Andreou presiding. In Puerto Rico, U.S. District Court for the District of Puerto Rico denied dismissal of negligence and nuisance claims in Jeanette Pérez-Maceira et al. v. Customed Inc. et al., No. 3:23-cv-01445 (D.P.R.), allowing discovery to proceed for a putative class. Pennsylvania state court rejected class certification for B. Braun Allentown facility residents in January 2026.
Key developments
PACER court filing on May 18: FRANCO v. B. BRAUN MEDICAL, INC.. ‖ Mshale news on Jun 5: EPA Moves To Weaken Air Pollution Limits For Chemical Linked To Cancer El Clasico (7fIOOVcDvK) - Mshale. ‖ EPA regulatory on Mar 25: ARC Specialty Pr. ‖ PubMed research on Jun 8: Exposure to environmental toxicants and obstructive sleep apnea: a cross-sectional study..
Generated Jun 13, 2026, 9:00 AM UTC